Representativeness of a National Heart Failure Quality-of-Care Registry-Reference-Cited by-同舟云学术

Representativeness of a National Heart Failure Quality-of-Care Registry

Published:2009-07 Issue:4 Volume:2 Page:377-384
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Curtis Lesley H.¹,Greiner Melissa A.¹,Hammill Bradley G.¹,DiMartino Lisa D.¹,Shea Alisa M.¹,Hernandez Adrian F.¹,Fonarow Gregg C.¹

Affiliation:

1. From the Center for Clinical and Genetic Economics, Duke Clinical Research Institute (L.H.C., M.A.G., B.G.H., L.D.D., A.M.S.), and Department of Medicine (L.H.C., A.F.H.), Duke University School of Medicine, Durham, NC; and Ahmanson-UCLA Cardiomyopathy Center, Department of Medicine (G.C.F.), UCLA Medical Center, Los Angeles, Calif.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts

2. Agency for Healthcare Research and Quality. Registries for Evaluating Patient Outcomes: A User’s Guide; 2007. http://effectivehealthcare.ahrq. gov/repFiles/PatOutcomes.pdf. Accessed September 17 2008.

3. Registries: what level of evidence do they provide?

4. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Insurance Status and Region on Angiotensin Receptor–Neprilysin Inhibitor Prescription During Heart Failure Hospitalizations;JACC: Heart Failure;2024-05

2. Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: Findings from GWTG-HF;American Heart Journal;2023-11

3. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors;The American Journal of Cardiology;2023-10

4. Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US;JAMA Cardiology;2023-07-01

5. Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults;JAMA Cardiology;2023-06-01